Ackermann H, Hertrich I, Ziegler W, Bitzer M, Bien S (1996) Acquired dysfluencies following infarction of the left mesiofrontal cortex. Aphasiology 10:409–417
Article
Google Scholar
Dion JE, Duckwiler GR, Vinuela F, Martin N, Bentson J (1990) Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage. Neuroradiology 32(3):232–236
Article
CAS
PubMed
Google Scholar
Diringer MN, Bleck TP, Claude Hemphill J III, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, Hanggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. doi:10.1007/s12028-011-9605-9
Google Scholar
Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3):CD000277. doi:10.1002/14651858.CD000277.pub3
Dorsch N (2011) A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl 110(Pt 1):5–6. doi:10.1007/978-3-7091-0353-1_1
PubMed
Google Scholar
Doukas A, Petridis AK, Barth H, Jansen O, Maslehaty H, Mehdorn HM (2011) Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. Acta Neurochirurgica Suppl 112:93–96. doi:10.1007/978-3-7091-0661-7_16
Article
CAS
Google Scholar
Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP (1982) Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11(3):337–343
Article
CAS
PubMed
Google Scholar
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10(7):618–625. doi:10.1016/S1474-4422(11)70108-9
Article
CAS
PubMed
Google Scholar
Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M, Schmiedek P, Vajkoczy P (2007) Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 35(8):1844–1851; quiz 1852. doi:10.1097/01.CCM.0000275392.08410.DD
Musahl C, Henkes H, Vajda Z, Coburger J, Hopf N (2011) Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Neurosurgery 68(6):1541–1547. doi:10.1227/NEU.0b013e31820edd46
Article
PubMed
Google Scholar
Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, Schurer L, Lumenta CB (2014) Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. BioMed Res Int 2014:970741. doi:10.1155/2014/970741
Article
PubMed
PubMed Central
Google Scholar
Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V (2005) Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 103(6):974–981. doi:10.3171/jns.2005.103.6.0974
Article
PubMed
Google Scholar
Weant KA, Ramsey CN 3rd, Cook AM (2010) Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. Pharmacotherapy 30(4):405–417. doi:10.1592/phco.30.4.405
Article
CAS
PubMed
Google Scholar
Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schurer L, Lumenta CB (2010) Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care 12(3):346–351. doi:10.1007/s12028-009-9317-6
Article
CAS
PubMed
Google Scholar